Datar Cancer Genetics 
Dealstreet

ELP advises Datar Cancer Genetics on its fund raise from Alkemi Growth Capital

Datar Cancer Genetics is a world-leading molecular oncology facility, having a wide national and international presence.

Bar & Bench

Economic Laws Practice (ELP) advised Datar Cancer Genetics Private Limited in raising an undisclosed amount from Alkemi Growth Capital LLP.

Economic Laws Practice (ELP) acted for Datar Cancer Genetics and the promoter of the Company on this transaction. ELP provided end-to-end advisory on the transaction including advisory, negotiations, markup of transaction documents.

The transaction team consisted of Yashojit Mitra (Partner), Manendra Singh (Partner) and Aditi Ladha (Senior Associate).

Yashojit Mitra, Manendra Singh

The fundraise will happen by way of subscription to compulsorily convertible preference shares and nominal equity shares in the Company.

Datar Cancer Genetics is a world-leading molecular oncology facility, having a wide national and international presence, with a fully equipped laboratory, integrated process platforms, an in-house bioinformatics team, and a huge genetic database for precise and updated reporting.

Alkemi Capital is a growth capital investment firm based in New Delhi, India, specializing in consumer wellness and healthcare industries. The firm invests in companies across various stages, with a focus on biotechnology, healthcare services, food products, and health-focused ventures

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

SEBI consent order cannot erase criminal liability: Bombay High Court

Raj Shamani moves Delhi High Court to protect his personality rights

'Khichdi served': Delhi High Court pulls up ED for freezing bank account based only on suspicion

AKS Partners shifts to larger office in Neeti Bagh, Delhi

ELP advises NXP USA Inc on $307 million acquisition of Kinara AI

SCROLL FOR NEXT